Table 1.
Demographic and clinical information of type 2 diabetes mellitus (DM) patients and control subjects.
| CTL | NDN | DN | |
|---|---|---|---|
| Number | 20 | 28 | 66 |
| Sex (male/female) | 12/8 | 18/10 | 32/34 |
| Age (years) | 46·5 (41·0–51·0) | 56·5 (53·0–59·0) | 57·0 (54·5–60·5) |
| FPG (mmol/l) | 5·1 (4·9–5·4) | 7·5 (5·8–8·4)b | 7·7 (6·2–9·0)b |
| Plasma Cr (μmol/l) | 81·0 (71·5–88·0) | 88·0 (77·5–100·0) | 114·5 (96·0–129·0)b, c |
| UACR (mg/mmol) | < 3·50 | 2·35 (0·95–3·50) | 34·0 (3·7–107·9)c |
| BMI | 23·0 (21·2–24·5) | 25·4 (23·0–29·1)a | 25·8 (24·3–28·1)b |
| WHR | 0·84 (0·81–0·86) | 0·94 (0·88–0·97)b | 0·93 (0·89–0·98)b |
CTL, control subjects; NDN, patients without diabetic nephropathy; DN, patients with diabetic nephropathy; FPG, fasting plasma glucose; Cr, creatinine; UACR, urine albumin: creatinine ratio; BMI, body mass index; WHR, waist to hip ratio. Data are expressed as median (interquartile range).
a
P < 0·01
b
P < 0·001 versus CTL
c
P < 0·001 versus NDN.